These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 17187067)

  • 1. The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy.
    Fischer J; Lefèvre C; Morava E; Mussini JM; Laforêt P; Negre-Salvayre A; Lathrop M; Salvayre R
    Nat Genet; 2007 Jan; 39(1):28-30. PubMed ID: 17187067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel duplication mutation in the patatin domain of adipose triglyceride lipase (PNPLA2) in neutral lipid storage disease with severe myopathy.
    Akiyama M; Sakai K; Ogawa M; McMillan JR; Sawamura D; Shimizu H
    Muscle Nerve; 2007 Dec; 36(6):856-9. PubMed ID: 17657808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5.
    Schweiger M; Lass A; Zimmermann R; Eichmann TO; Zechner R
    Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E289-96. PubMed ID: 19401457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene.
    Reilich P; Horvath R; Krause S; Schramm N; Turnbull DM; Trenell M; Hollingsworth KG; Gorman GS; Hans VH; Reimann J; MacMillan A; Turner L; Schollen A; Witte G; Czermin B; Holinski-Feder E; Walter MC; Schoser B; Lochmüller H
    J Neurol; 2011 Nov; 258(11):1987-97. PubMed ID: 21544567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lack of the C-terminal domain of adipose triglyceride lipase causes neutral lipid storage disease through impaired interactions with lipid droplets.
    Kobayashi K; Inoguchi T; Maeda Y; Nakashima N; Kuwano A; Eto E; Ueno N; Sasaki S; Sawada F; Fujii M; Matoba Y; Sumiyoshi S; Kawate H; Takayanagi R
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2877-84. PubMed ID: 18445677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement.
    Missaglia S; Maggi L; Mora M; Gibertini S; Blasevich F; Agostoni P; Moro L; Cassandrini D; Santorelli FM; Gerevini S; Tavian D
    Neuromuscul Disord; 2017 May; 27(5):481-486. PubMed ID: 28258942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review.
    Kaneko K; Kuroda H; Izumi R; Tateyama M; Kato M; Sugimura K; Sakata Y; Ikeda Y; Hirano K; Aoki M
    Neuromuscul Disord; 2014 Jul; 24(7):634-41. PubMed ID: 24836204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with neutral lipid storage disease with myopathy (NLSDM) in Southwestern China.
    Tan J; Yang H; Fan J; Fan Y; Xiao F
    Clin Neurol Neurosurg; 2018 May; 168():102-107. PubMed ID: 29539587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neutral lipid storage diseases and ATGL (adipose triglyceride lipase) and CGI-58/ABHD5 (alpha-beta hydrolase domain-containing 5) deficiency: myopathy, ichthyosis, but no obesity].
    Fischer J; Negre-Salvayre A; Salvayre R
    Med Sci (Paris); 2007; 23(6-7):575-8. PubMed ID: 17631826
    [No Abstract]   [Full Text] [Related]  

  • 10. Symptomatic lipid storage in carriers for the PNPLA2 gene.
    Janssen MC; van Engelen B; Kapusta L; Lammens M; van Dijk M; Fischer J; van der Graaf M; Wevers RA; Fahrleitner M; Zimmermann R; Morava E
    Eur J Hum Genet; 2013 Aug; 21(8):807-15. PubMed ID: 23232698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutations in the adipose triglyceride lipase gene causing neutral lipid storage disease with myopathy.
    Campagna F; Nanni L; Quagliarini F; Pennisi E; Michailidis C; Pierelli F; Bruno C; Casali C; DiMauro S; Arca M
    Biochem Biophys Res Commun; 2008 Dec; 377(3):843-6. PubMed ID: 18952067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene.
    Fiorillo C; Brisca G; Cassandrini D; Scapolan S; Astrea G; Valle M; Scuderi F; Trucco F; Natali A; Magnano G; Gazzerro E; Minetti C; Arca M; Santorelli FM; Bruno C
    Biochem Biophys Res Commun; 2013 Jan; 430(1):241-4. PubMed ID: 23146629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel missense mutations in PNPLA2 causing late onset and clinical heterogeneity of neutral lipid storage disease with myopathy in three siblings.
    Missaglia S; Tasca E; Angelini C; Moro L; Tavian D
    Mol Genet Metab; 2015; 115(2-3):110-7. PubMed ID: 25956450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of induced Pluripotent Stem Cells as disease modelling of NLSDM.
    Tavian D; Missaglia S; Castagnetta M; Degiorgio D; Pennisi EM; Coleman RA; Dell'Era P; Mora C; Angelini C; Coviello DA
    Mol Genet Metab; 2017 May; 121(1):28-34. PubMed ID: 28391974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel
    Tavian D; Maggi L; Mora M; Morandi L; Bragato C; Missaglia S
    Genes Dis; 2021 Jan; 8(1):73-78. PubMed ID: 33569515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A myopathy with unusual features caused by PNPLA2 gene mutations.
    Pennisi EM; Missaglia S; Dimauro S; Bernardi C; Akman HO; Tavian D
    Muscle Nerve; 2015 Apr; 51(4):609-13. PubMed ID: 25287355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel PNPLA2 gene mutations in Chinese Han patients causing neutral lipid storage disease with myopathy.
    Lin P; Li W; Wen B; Zhao Y; Fenster DS; Wang Y; Gong Y; Yan C
    J Hum Genet; 2012 Oct; 57(10):679-81. PubMed ID: 22832386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutral lipid storage disease with myopathy and dropped head syndrome. Report of a new variant susceptible of treatment with late diagnosis.
    Garcia MA; Rojas JA; Millán SP; Flórez AA
    J Clin Neurosci; 2018 Dec; 58():207-209. PubMed ID: 30352762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome.
    Lass A; Zimmermann R; Haemmerle G; Riederer M; Schoiswohl G; Schweiger M; Kienesberger P; Strauss JG; Gorkiewicz G; Zechner R
    Cell Metab; 2006 May; 3(5):309-19. PubMed ID: 16679289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation in PNPLA2 leading to neutral lipid storage disease with myopathy.
    Ash DB; Papadimitriou D; Hays AP; Dimauro S; Hirano M
    Arch Neurol; 2012 Sep; 69(9):1190-2. PubMed ID: 22964912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.